Sharon Benzeno, Chief Commercial Ofc Imm Med at Adaptive Biotechnologies Corp (ADPT), sold 48,034 shares at $3.44 ($165K) on 2024-03-05, disclosed to the SEC on 2024-03-06.
Seasonal sale ($165k) by Chief Commercial Ofc Imm Med — this insider has traded ADPT in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.43 | 10,746 | $37K | 22.3% |
| 2 | $3.44 | 18,644 | $64K | 38.8% |
| 3 | $3.44 | 18,644 | $64K | 38.8% |
| Total | $3.44 avg | 48,034 | $165K | 100% |
| Filing → |
| ADPT | SELL | 2025-12-08 | $425K | — | Filing → |
| ADPT | SELL | 2025-11-24 | $20.3M | — | Filing → |
| ADPT | SELL | 2025-03-06 | $312K | — | Filing → |